Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 15 | Leaver AndrewChief Executive Officer | Other acquisition or disposition | J | $69K 2,818 sh | Oct 7, 2026 |
| 15 | Gruber JulieChief Legal&Compliance Officer | Open-market sale · 10b5-1 plan | SELL | $649K 27.5K sh | Oct 7, 2026 traded Oct 6, 2026 |
| 15 | ten Bosch John RoderickSVP of Laboratory Operations | Open-market sale · 10b5-1 plan | SELL | $149K 1,417 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 15 | ten Bosch John RoderickSVP of Laboratory Operations | Open-market sale · 10b5-1 plan | SELL | $149K 1,417 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 15 | Sahin UgurChief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $2.30M 24.0K sh | Oct 7, 2026 traded Oct 7, 2026 |
| 15 | Tsao DavidDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $205K 1,909 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 15 | Tsao DavidDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $59K 555 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 15 | McLaughlin John CharlesChief Transformation Officer | Tax withholding | F | $4,913 618 sh | Oct 7, 2026 traded Oct 2, 2026 |
| 14 | Ong Chin YinChief Org Capability Officer | Open-market sale · 10b5-1 plan | SELL | $117K 38.0K sh | Oct 7, 2026 traded Oct 5, 2026 |
| 14 | Maetzold Derek JDirector, Pres. & Chief Exec. Officer | Open-market sale · 10b5-1 plan | SELL | $114K 3,198 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 14 | Maetzold Derek JDirector, Pres. & Chief Exec. Officer | Open-market sale · 10b5-1 plan | SELL | $97K 2,718 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 14 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $392K 2,091 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 14 | Sauer Richard HarryChief Legal Officer & Secty | Tax withholding | F | $1.26M 6,783 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 14 | Duffy Matthew PaulPresident & Chief Risk Officer, Positions held at subsidiary | Open-market sale · 10b5-1 plan | SELL | $1.12M 41.4K sh | Oct 7, 2026 traded Oct 6, 2026 |
| 14 | Enslin RobertPresident, CCO | Open-market sale · 10b5-1 plan | SELL | $317K 1,700 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 13 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $44K 200 sh | Oct 7, 2026 traded Oct 6, 2026 |
| 13 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $42K 200 sh | Oct 7, 2026 traded Oct 6, 2026 |
| 13 | Verma AbhimanyuChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $43K 5,284 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 13 | Caron Michelle ElizabethChief Financial Officer | Tax withholding | F | $49K 1,743 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 13 | Kaiser Joseph JohnDirector | Grant or award | A | $21K 2,046 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 13 | Holme TimothyCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $102K 22.5K sh | Oct 7, 2026 traded Oct 5, 2026 |
| 13 | Nilan Nicholas WilliamGeneral Manager-US | Option exercise | M | — 959 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 13 | Ilg Thomas GregorChief Risk Officer | Grant or award | A | — 18.3K sh | Oct 7, 2026 traded Oct 6, 2026 |
| 13 | Lefebvre d'Ovidio ManfrediDirector | Option exercise | M | — 1,111 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 13 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $45K 200 sh | Oct 7, 2026 traded Oct 6, 2026 |
| 13 | Calabria CarloDirector | Option exercise | M | — 66 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 13 | Holme TimothyCHIEF TECHNOLOGY OFFICER | Open-market sale · 10b5-1 plan | SELL | $102K 22.5K sh | Oct 7, 2026 traded Oct 5, 2026 |
| 13 | Valente ManuelaChief People Officer | Open-market sale · 10b5-1 plan | SELL | $34K 4,240 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 13 | Cheng Chi FungDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $21K 100 sh | Oct 7, 2026 traded Oct 6, 2026 |
| 13 | Reynoso Jamie L.CEO, Medicare Advantage | Open-market sale · 10b5-1 plan | SELL | $9,288 2,006 sh | Oct 7, 2026 traded Oct 7, 2026 |
| 13 | Calabria CarloDirector | Option exercise | M | — 83 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 13 | Armstrong Jason J.Chief Financial Officer | Grant or award | A | — 35.0K sh | Oct 7, 2026 traded Oct 6, 2026 |
| 13 | Cardoza GeorgeChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $13K 1,592 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 13 | Lefebvre d'Ovidio ManfrediDirector | Option exercise | M | — 83 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 12 | Puccio Richard C JrChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $632K 1,500 sh | Oct 7, 2026 traded Oct 6, 2026 |
| 12 | Yeh Shu-Hua (Joshua)*** See Remarks | Open-market sale · 10b5-1 plan | SELL | $720K 6,000 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 12 | Tsao DavidDirector, Chief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $11K 100 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 12 | Allaire JeremyDirector, Chairman and CEO | Open-market sale · 10b5-1 plan | SELL | $1.08M 13.0K sh | Oct 7, 2026 traded Oct 5, 2026 |
| 12 | Mock James MChief Financial Officer | Tax withholding | F | $134K 704 sh | Oct 7, 2026 traded Oct 5, 2026 |
| 12 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.24M 28.8K sh | Oct 7, 2026 traded Oct 6, 2026 |